Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL.
Global epidemiology of HTLV-I infection and associated diseases.
Oncogene 2005; 24:6058-6068.
2. Farid R, Etemadi M, Baradaran H, Nikbin B. Seroepidemiology
and virology of HTLV-I in the city of Mashhad, northeastern Iran.
Serodiag Immun Inf D 1993; 5:251-252.
3. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand
M, Abbaszadegan M. Prevalence of human T-lymphotropic
virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol
2003; 41:2593-2595.
4. Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Pinheiro SR,
Guedes AC,
et al.
Epidemiology, treatment, and prevention of human
T-cell leukemia virus type 1-associated diseases. Clin Micro
277
Dermatologic Manifestation in HTLV-I Carriers Yazdanpanah MJ R et al
Iran J Basic Med Sci; Vol. 16, No. 3, Mar 2013
biol Rev 2010; 23:577-589.
5. Blattner W, Charurat M. Human T-cell lymphotropic virus type
1 and 2. In: Principle and practice of infectious disease. (Mandell
G, Bennet JE, Dolin R, ed). 6th ed. Philadelphia: Elsevier;
2005.p.2098-2118.
6. Goncalves DU, Guedes AC, Proietti AB, Martins ML, Proietti FA,
Lambertucci JR. Interdisciplinary HTLV-I/II Research Group: Dermatologic
lesions in asymptomatic blood donors seropositive
for human T cell lymphotropic virus type-I. Am J Trop Med Hyg
2003; 68:562-565.
7. Nobre V, Guedes AC, Proietti FA,
et al
. Increased prevalence of
human T cell lymphotropic virus type 1 in patients attending a
Brazilian dermatology clinic. Intervirology 2007; 50:316-318.
8. Nobre V, Guedes AC, Martins ML, Barbosa-Stancioli EF, Serufo JC,
Proietti FA,
et al
. Dermatological findings in 3 generations of a
family with a high prevalence of human T cell lymphotropic virus
type 1 infection in Brazil. Clin Infect Dis 2006; 43:1257-1263.
9. Watanabe A, Kawajiri M, Ikezoe K, Osoegawa M, Murai H, Ochi H
,
et al
. HTLV-I-associated myelopathy/tropical spastic paraparesis
accompanied with psoriasis. J Neurol Sci 2004; 221:95-97.
10. Guillevin L, Cohen P. Polyarteritis nodosa: clinical, prognostic
and therapeutic features. Ann Med Int 2000; 151:184-192.
11. Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical
and immunological findings in seventy-eight patients and a
review of the literature. J Infect 2005; 50:375-381.
12. Amano M, Setoyama M, Grant A, Kerdel FA. Human T-lymphotropic
virus 1 (HTLV-I) infection--dermatological implications.
Int J Dermatol 2011; 50:915-920.
13. Arfi S, Durget D, Vernant JCI, Numeric P, De Thore J, Jean-Baptiste
G.Dermatopolymyositis in Martinique. Relations with the virus.
Rev Med Int 1992; 13:S452.
14. Bataille V, Harland CC, Behrens J, Cook MG, Holden CA. Kikuchi
disease (histiocytic necrotizing lymphadenitis) in association
with HTLV-I. Br J Dermatol 1997; 136:610-612.
15. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective
dermatitis of Jamaican children: a marker for HTLV-I infection.
Lancet 1990; 336:1345-1347.
16. Oliveira Mde F, Brites C, Ferraz N, Magalhaes P, Almeida F, Bittencourt
AL. Infective dermatitis associated with the human T cell
lymphotropic virus type I in Salvador, Bahia, Brazil. Clin Infect
Dis 2005; 40:e90-96.
17. Maragno L, Casseb J, Fukumori LM, Sotto MN, Duarte AJ, Festa-
Neto C,
et al
. Human T-cell lymphotropic virus type 1 infective
dermatitis emerging in adulthood. Int J Dermatol 2009; 8:723-
730.
18. Sanchez-Palacios C, Gotuzzo E, Vandamme AM, Maldonado Y.
Seroprevalence and risk factors for human T-cell lymphotropic
virus (HTLV-I) infection among ethnically and geographically diverse
Peruvian women. Int J Infect Dis 2003; 7:132-137.
19. Soares BC, Proietti AB, Proietti FA. Interdisciplinary HTLV-I/II
Research Group. HTLV-I/II and blood donors: determinants associated
with seropositivity in a low risk population. Rev Saude
Publica 2003; 37:470-476.
20. Lewkowicz N, Lewkowicz P, Banasik M, Kurnatowska A, Tchorzewski
H. Predominance of Type 1 cytokines and decreased number
of CD4 (+) CD25 (+high) T regulatory cells in peripheral blood of
patients with recurrent aphthous ulcerations. Immunol Lett
2005; 99:57-62.
21. Tiemessen MM, Mitchell TJ, Hendry L, Whittaker SJ, Taams LS,
John S. Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced
stages of primary cutaneous T-cell lymphoma. J Invest
Dermatol 2006; 126:2217-2223.
22. Karube K, Ohshima K, Tsuchiya T,
et al
. Expression of FoxP3, a key
molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/
lymphoma cells. Br J Haematol 2004; 126:81-84.
23. Yamano Y, Takenouchi N, Li HC,
et al
. Virus-induced dysfunction
of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological
disease. J Clin Invest 2005; 115:1361-1368.
24. Kuroda Y, Takashima H. Impairment of cell-mediated immune
responses in HTLV-I-associated myelopathy. J Neurol Sci 1990;
100:211-216.
25. Remondegui C, Bueno J, Pintado A. AIDS Research and Human
Retroviruses: A case of strongyloidosis hyperinfection in a
HTLV-I carrier. 10th International Conference on Human Retro
virology: HTLV and Related Viruses. 2001 June 25-29;Dublin
Ireland:2001.p.142.
26. Ajithkumar K, Ramalingam S, Kannangai R, Prakash KJ. Human T
lymphotrophic virus-I (HTLV-I) infection in patients with unclassifiable
dermatitis in central Kerala, south India: a preliminary
study. Sex Transm Infect 2002; 78:E7.
27. Nobre V, Guedes AC, Proietti FA,
et al
. Dermatologic lesions in patients
infected with the human T-cell lymphotropic virus type 1
(HTLV-I). Rev Soc Bras Med Trop 2005; 38:43-52.
28. Del Giudice P. Scabies in HTLV-I seropositive patients. J Am Acad
Dermatol 1997; 36:134-135.
29. Javidi Z, Farid R, Taheri AR,
et al
. A study of HTLV-I seroposetivity
in vitiligo. Med J Mashhad Univ Med Sci 2004; 82:114-119.(Persian)
30. Sharata HH, Colvin JH, Fujiwara K, Goldman B, Hashimoto K. Cutaneous
and neurologic disease associated with HTLV-I infection.
J Am Acad Dermatol 1997; 36:869-871.
31. Primo J, Siqueira I, Nascimento MC, Oliveira MF, Farre L, Carvalho
EM,
et al.
High HTLV-I proviral load, a marker for HTLV-I associated
myelopathy/tropical spastic paraparesis, is also detected in
patients with infective dermatitis associated with HTLV-I. Braz J
Med Biol Res 2009; 42:761-764.
32. Nascimento MC, Primo J, Bittencourt A, Siqueira I, de Fatima
Oliveira M, Meyer R, Schriefer A, Santos SB, Carvalho EM. Infective
dermatitis has similar immunological features to human T lymphotropic
virus-type 1-associated myelopathy/tropical spastic
paraparesis. Clin Exp Immunol 2009; 156:455-62.
)